81 related articles for article (PubMed ID: 5084947)
41. Proceedings: cellular immunity to malignant melanoma.
Grant RM; Cochran AJ; Thomas CE; Mackie RM; Cameron-Mowat DE; Spilg WG; Norman JN
Br J Surg; 1973 Nov; 60(11):905. PubMed ID: 4752760
[No Abstract] [Full Text] [Related]
42. Targets of protective tumor immunity.
Dranoff G
Ann N Y Acad Sci; 2009 Sep; 1174():74-80. PubMed ID: 19769739
[TBL] [Abstract][Full Text] [Related]
43. Surgery-induced immunomodulation in breast cancer.
Chen XB; Fang XD; Zhang HL
J Surg Oncol; 2011 Feb; 103(2):197; author reply 196. PubMed ID: 21259258
[No Abstract] [Full Text] [Related]
44. Antimelanoma immunity in vitiligo and melanoma patients.
Juranic ZD; Stanojevic-Bakic N; Zizak Z; Babovic N; Radovic-Kovacevic V; Stanojkovic T; Dzodic R
Neoplasma; 2003; 50(4):305-9. PubMed ID: 12937846
[TBL] [Abstract][Full Text] [Related]
45. Suppressed cellular immunity in mice harboring intraocular melanomas.
Niederkorn JY
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):447-54. PubMed ID: 6608506
[TBL] [Abstract][Full Text] [Related]
46. Expression of tumour-associated antigens in breast cancer primary tissue compared with serum levels.
Cannon PM; Ellis IO; Blamey RW; Bell J; Elston CW; Robertson JF
Eur J Surg Oncol; 1993 Dec; 19(6):523-7. PubMed ID: 8270037
[TBL] [Abstract][Full Text] [Related]
47. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
Cervantes C; Muzio E; Exposito G; Garcia ME
Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
[TBL] [Abstract][Full Text] [Related]
48. Regression of malignant melanoma as a manifestation of a cellular immunity response.
Lloyd OC
Proc R Soc Med; 1969 Jun; 62(6):543-5. PubMed ID: 5802725
[No Abstract] [Full Text] [Related]
49. [Immunomorphology in oncology].
Rimondi AP; Cavazzini L; Nenci I
Minerva Med; 1982 Apr; 73(18):1139-44. PubMed ID: 6979009
[No Abstract] [Full Text] [Related]
50. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
[TBL] [Abstract][Full Text] [Related]
51. Proceedings: effect of surgery under anaesthesia on tumour-directed leucocyte responses.
Moudgil GC; Vose BM
Br J Anaesth; 1975 May; 47(5):631-2. PubMed ID: 1138783
[No Abstract] [Full Text] [Related]
52. [Immunologic indices in patients with cancer of the breast following surgical treatment].
Iarygin LM; Malyshev VS; Denisov LE; Zimin IuI
Khirurgiia (Mosk); 1988 Nov; (11):42-6. PubMed ID: 3210623
[No Abstract] [Full Text] [Related]
53. [Immunogic efficiency in patients with breast neoplasms. I. Cellular response to autologous breast cancer tissue].
Smolak K
Nowotwory; 1977; 27(2):119-28. PubMed ID: 331271
[No Abstract] [Full Text] [Related]
54. Letter: Cryostat sections in immunological studies of cancer.
Black MM
Lancet; 1973 Dec; 2(7841):1326. PubMed ID: 4127669
[No Abstract] [Full Text] [Related]
55. Letter: Correlation between tests of cell-mediated immunity.
Whitehead RH; Teasdale C; Hughes LE
Lancet; 1976 Jul; 2(7979):258. PubMed ID: 59271
[No Abstract] [Full Text] [Related]
56. Beneficial and detrimental effects of therapy on immunity in breast cancer.
Order SE
Int J Radiat Oncol Biol Phys; 1977; 2(3-4):377-80. PubMed ID: 863770
[No Abstract] [Full Text] [Related]
57. An example of a test for adaptive techniques in a medical investigation.
Gagliardo E
Comput Biol Med; 1975 Jun; 5(1-2):97-104. PubMed ID: 1098846
[No Abstract] [Full Text] [Related]
58. [Cellular immunity and its prognostic value in patients with breast cancer (proceedings)].
Kitschke HJ; Buddemeier D; Krebs D
Arch Gynakol; 1977 Jul; 224(1-4):475-6. PubMed ID: 579916
[No Abstract] [Full Text] [Related]
59. Post-operative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Thomas CE; McKie RM; Spilg WG
J Pathol; 1972 Jul; 107(3):Pv. PubMed ID: 5084947
[No Abstract] [Full Text] [Related]
60. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
